Role of calcineurin in the progression of cardiac hypertrophy in renovascular hypertensive rats

Acta Physiologica Sinica

Volumn 55, Issue 5, 2003, Pages 594-598

  Sheng, Hong Zhuan ^a,b   Zhang, Ji Nan ^a   Yang, Di ^a   Yang, Guo Ping ^a   Xu, Jin Dan ^a   Chen, Xiang Jian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANTONG MEDICAL COLLEGE   (China)

Author keywords

Caleineurin; Cardiomegaly; Cyclosporine A; Physiology; Renovascular hypertension

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOSPORIN A; MESSENGER RNA; SODIUM CHLORIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION;

ANIMALS; CALCINEURIN; CYCLOSPORINE; HYPERTENSION, RENOVASCULAR; HYPERTROPHY, LEFT VENTRICULAR; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0242543039     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Katz AM. Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Eng J Med 1990; 322: 100-110.
2. Levy D, Garrison RJ, Savage DD. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561-1566.
3. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215-228.
4. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 1998; 281: 1690-1693.
5. Taigen T, De Windt LJ, Lim HW, Molkentin JD. Target inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2000; 97: 1196-1201.
6. Zou YZ, Hiroi Y, Uozumi H, Takimoto E, Toko H, Zhu WD, Kudoh S, Mizukami M, Shimoyama M, Shibasaki F, Nagai R, Yazaki Y, Komuro I. Calcuneurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy. Circulation 2001; 104: 97-101.
7. Shimoyama M, Hayashi D, Zou YZ, Takimoto E, Mizukami M, Monzen K, Kudoh S, Hiroi Y, Yazaki Y, Nagai R, Komuro I. Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension. Circulation 2000; 102: 1996-2004.
8. Lim HW, Windt LJ, Steinberg L, Taigen T, Witt SA, Kimball TR, Molkentin JD. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation 2000; 101: 2431-2437.
9. Lim HW, Windt LJ, Mante J, Kimball TR, Witt SA, Sussman MA, Molkentin JD. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition. J Mol Cell Cardiol 2000; 32: 697-709.
10. 2+/calmodulin-dependent protein phosphatase (calcineurin Bα2). Biochim Biophys Acta 1994; 1217: 174-180.
11. Sawa A, Khan AA, Hester LD, Snyder SH. Glycersaldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci USA 1997; 94: 11669-11674.
12. Fu MG, Xu S, Pang YZ, Liu NK, Tang CS. Role of calcineurin in signal transduction of bFGF-induced cardiac myocyte hypertrophy of rats. J Peking Univ 2001; 33 (1): 38-41 (Chinese, English abstract).
13. Bianciotti LG, Bold AJ. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension. Cardiovas Res 2001; 49: 808-816.
14. Murat A, Pellieux C, Brunner HR, Pedrazzini T. Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension. J Biol Chem 2000; 275 (52): 40867-40873.
15. Ritter O, Hack S, Schuh K, Rothlein N, Perrot A, Osterziel K, Schulte HD, Neyses L. Calcineurin in human heart hypertrophy. Circulation 2002; 105: 2265-2269.
16. Hill JA, Rothermel B, Yoo KD, Cabuay B, Demetroulis E, Weiss RM, Kutschke W, Bassel-Duby R, Williams S. Targeted inhibition of calcineurin in pressure-overloac cardiac hypertrophy. J Biol Chem 2002; 277: 10251-10255.
17. Windt LJ, Lim HW, Haq S, Force T, Molkentin JD. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. J Biol Chem 2000; 275: 13571-13579.
18. Yin FC, Spurgeon HA, Rakusan K, Weisfeldt ML, Lakatta EG. Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol 1982; 243: H941-H947.